China Resources Boya Bio-pharmaceutical Group Co.,Ltd Stock
Equities
300294
CNE100001FF1
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
31.37 CNY | -1.07% | +1.23% | -6.86% |
Sales 2024 * | 1.91B 263M | Sales 2025 * | 2.08B 287M | Capitalization | 15.82B 2.18B |
---|---|---|---|---|---|
Net income 2024 * | 549M 75.77M | Net income 2025 * | 603M 83.23M | EV / Sales 2024 * | 8.29 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 7.62 x |
P/E ratio 2024 * |
28.8
x | P/E ratio 2025 * |
26.3
x | Employees | 1,444 |
Yield 2024 * |
0.99% | Yield 2025 * |
1.12% | Free-Float | 16.25% |
1 day | -1.07% | ||
1 week | +1.23% | ||
Current month | +9.23% | ||
1 month | +16.75% | ||
3 months | +7.10% | ||
6 months | +10.93% | ||
Current year | -6.86% |
Managers | Title | Age | Since |
---|---|---|---|
Xiao Ming Liang
CEO | Chief Executive Officer | 57 | 93-11-05 |
Hua Cheng Liang
DFI | Director of Finance/CFO | 42 | 21-08-31 |
Zhen Rao
BRD | Director/Board Member | 56 | 93-11-05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Wei Dong Zhang
BRD | Director/Board Member | 61 | 21-02-02 |
Xiao Ming Liang
CEO | Chief Executive Officer | 57 | 93-11-05 |
Zhen Rao
BRD | Director/Board Member | 56 | 93-11-05 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 31.37 | -1.07% | 5,096,226 |
24-04-24 | 31.71 | +1.73% | 6,388,069 |
24-04-23 | 31.17 | -1.08% | 3,906,015 |
24-04-22 | 31.51 | -0.41% | 4,949,545 |
24-04-19 | 31.64 | +2.10% | 4,961,426 |
End-of-day quote Shenzhen S.E., April 24, 2024
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.86% | 2.18B | |
-4.66% | 87.53B | |
+2.63% | 40.42B | |
-21.76% | 29.48B | |
+55.26% | 25.43B | |
-14.78% | 15.59B | |
-18.49% | 11.49B | |
-15.61% | 11.1B | |
-44.02% | 11.3B | |
+4.49% | 8.75B |
- Stock Market
- Equities
- 300294 Stock